Position in RVTY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,373,630
+$4,373,630 QoQ
Shares Held
39,310
Ownership
0.035%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#116
of 538 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in RVTY
reported options exposure · as of Jun 30, 2026CallValue
$2,536,728
CallShares
22,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PEAK6 LLC holds $14,523,801 across 10 Diagnostics & Research names. RVTY ranks #2 (30.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
47,976 | $6,372,652 | |
| 2 | RVTY |
Revvity, Inc.
This page
|
39,310 | $4,373,630 | |
| 3 | DHR |
Danaher Corp /De/
|
14,717 | $2,803,294 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
2,447 | $472,809 | |
| 5 | NEO |
Neogenomics Inc
|
25,575 | $373,139 | |
| 6 | DGX |
Quest Diagnostics Inc
|
520 | $110,214 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
28 | $14,740 | |
| 8 | TMO |
Thermo Fisher Scientific Inc.
|
3 | $1,504 |
All Filings in RVTY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,536,728 | 22,800 | Call | Defined | 2026-08-13 | |
| 2026-06-30 | $4,373,630 | 39,310 | Shares | Defined | 2026-08-13 | |
| 2025-12-31 | $841,725 | 8,700 | Call | Defined | 2026-03-12 | |
| No filing history on record for this holder in this stock. | ||||||